Skip to content
10-K

Annual Report

Raphael Pharmaceutical Inc. RAPH

0001213900-24-027234

← back to feed
Filed
Mar 28, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 28, 2024 18.66M sh
Capex FY 2023 · Dec 31, 2022 $2K